The promise and potential of liver organoids: Development, classification and application
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-Oct-2026 04:16 ET (30-Oct-2026 08:16 GMT/UTC)
Liver organoids, three-dimensional structures derived from stem cells or hepatic progenitors, have emerged as a transformative technology. Unlike traditional two-dimensional cultures or animal models, organoids faithfully recapitulate the complex architecture and functionality of native liver tissue. This review summarizes recent advancements in liver organoid technology, detailing their development, classification, and key applications.
Aging is a complex process, and precisely measuring how the human body declines has long been a challenge. Two people of the same chronological age can have very different health trajectories. Scientists have also struggled to move beyond identifying aging markers to pinpointing what actually drives aging itself. Now researchers from China’s Aging Biomarker Consortium (ABC) have built a computational framework—the Digital Aging Twin—to study aging at the individual level in order to predict biological age and track the different aging rates of individual organs.
Living tissues do not change through biology alone.
A new study reveals that reptile species richness peaks at mid-elevations and that woodland cover creates divergent habitat preferences across lizards, snakes, and chelonians.
A research team has successfully removed the primary obstacle to post-silicon computing by using a room-temperature printing process to create a record-breaking electronic connection for atomic-thin materials.
By applying a 3.6-nanometer-thick "skin" of gallium oxide GaOx between metal wires and a semiconductor sheet, the researchers achieved an electron mobility of 296 cm2·V−1·s−1 - the highest ever recorded for this type of material.
Over the past decade, organoid research has boomed and revolutionized biomedicine, with wide industrial applications and regulatory recognition. However, comprehensive reviews on organoid-related regulations and IND-approved drugs remain insufficient. This article reviews relevant advances in regulations and IND applications, and discusses the prospects and limitations of organoid models.